Literature DB >> 8522836

Immunotherapy with Mycobacterium vaccae combined with second line chemotherapy in drug-resistant abdominal tuberculosis.

J G Prior1, A A Khan, K A Cartwright, P A Jenkins, J L Stanford.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8522836     DOI： 10.1016/s0163-4453(95)91488-9

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  2 in total

Review 1.  Treatment and prevention of multidrug-resistant tuberculosis.

Authors:  I Bastian; R Colebunders
Journal:  Drugs       Date:  1999-10       Impact factor: 9.546

2.  Immunotherapeutic efficacy of recombinant Mycobacterium smegmatis expressing Ag85B-ESAT6 fusion protein against persistent tuberculosis infection in mice.

Authors:  Ping Wang; Limei Wang; Wei Zhang; Yinlan Bai; Jian Kang; Yanfei Hao; Tailai Luo; Changhong Shi; Zhikai Xu
Journal:  Hum Vaccin Immunother       Date:  2013-08-27       Impact factor: 3.452
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.